BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7334075)

  • 1. Antigenic scheme of Citrobacter koseri.
    Sechter I; Altmann G; Cahan D; Braunstein I; Gerichter CB
    J Clin Microbiol; 1981 Dec; 14(6):620-2. PubMed ID: 7334075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrobacter koseri. I. An extended antigenic scheme for Citrobacter koser (syn. C. diversus, Levinea malonatica).
    Gross RJ; Rowe B
    J Hyg (Lond); 1975 Aug; 75(1):121-7. PubMed ID: 1097496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sero- and biovars of Levinea malonatica (syn. Citrobacter diversus, Citrobacter koseri) in clinical material (author's transl)].
    Aleksić S; Sechter I; Katz A
    Zentralbl Bakteriol A; 1981 Aug; 249(3):373-81. PubMed ID: 7269856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic scheme for Citrobacter koseri (syn. C. diversus, Levinea malonatica); three new antigens recognized in strains from Israel.
    Gross RJ; Rowe B; Sechter I; Cahan D; Altman G
    J Hyg (Lond); 1981 Feb; 86(1):111-5. PubMed ID: 7007489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the surface structures of bacteria as a cause of weak immunogenicity of vaccines from several strains of Citrobacter].
    Feĭgin S; Kushnarev VM; Tsvetkova NV; Gromova LA; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):78-81. PubMed ID: 1015081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flagellar antigens of E. coli serologically interrlelated to H40, 41 and H41, 42, 43 flagellar antigens of Citrobacter. New H-antigeny E. coli i Citrobacter].
    Ratiner IuA; Raginskaia VP; Lifshits MB; Sycheva AM; Butuzova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):50-6. PubMed ID: 78607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotyping of strains belonging to the Citrobacter-Levinea group isolated from diagnostic material.
    Sourek J; Aldová E
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):480-90. PubMed ID: 936828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-speciation of the original reference strains of serovars in the Citrobacter freundii (Bethesda-Ballerup group) antigenic scheme of West and edwards.
    Miki K; Tamura K; Sakazaki R; Kosako Y
    Microbiol Immunol; 1996; 40(12):915-21. PubMed ID: 9013489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteraemia caused by non-freundii, non-koseri Citrobacter species in Taiwan.
    Lai CC; Tan CK; Lin SH; Liu WL; Liao CH; Huang YT; Hsueh PR
    J Hosp Infect; 2010 Dec; 76(4):332-5. PubMed ID: 20708303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum management of Citrobacter koseri infection.
    Deveci A; Coban AY
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1137-42. PubMed ID: 25088467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. fliP influences Citrobacter koseri macrophage uptake, cytokine expression and brain abscess formation in the neonatal rat.
    Townsend SM; Gonzalez-Gomez I; Badger JL
    J Med Microbiol; 2006 Dec; 55(Pt 12):1631-1640. PubMed ID: 17108264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-classification within the serogroups O3 and O8 of Citrobacter strains.
    Katzenellenbogen E; Staniszewska M; Kocharova NA; Mieszała M; Korzeniowska-Kowal A; Górska S; Knirel YA; Gamian A
    BMC Microbiol; 2017 Jul; 17(1):169. PubMed ID: 28750622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical identification of citrobacteria in the clinical laboratory.
    Janda JM; Abbott SL; Cheung WK; Hanson DF
    J Clin Microbiol; 1994 Aug; 32(8):1850-4. PubMed ID: 7989531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Citrobacter in clinical disease of children: review.
    Doran TI
    Clin Infect Dis; 1999 Feb; 28(2):384-94. PubMed ID: 10064257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol utilization by Citrobacter koseri promotes brain infection.
    Yuan C; Yang P; Wang J; Jiang L
    Biochem Biophys Res Commun; 2019 Sep; 517(3):427-432. PubMed ID: 31376937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotyping of Serratia marcescens: current status of seven recently described flagellar (H) antigens.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1979 Jul; 10(1):56-63. PubMed ID: 387810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of rapid and simple experimental and in silico serotyping systems for Citrobacter.
    Qian C; Du Y; Li H; Wu P; Wang L; Wei Y; Cao H; Yin Z; Zhang Y; Zhu Y; Guo X; Liu B
    Future Microbiol; 2018 Oct; 13(13):1511-1522. PubMed ID: 30099919
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kataoka H; Mori T; Into T
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33439115
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain abscess caused by Citrobacter koseri infection in an adult.
    Liu HW; Chang CJ; Hsieh CT
    Neurosciences (Riyadh); 2015 Apr; 20(2):170-2. PubMed ID: 25864072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies.
    Brenner DJ; Grimont PA; Steigerwalt AG; Fanning GR; Ageron E; Riddle CF
    Int J Syst Bacteriol; 1993 Oct; 43(4):645-58. PubMed ID: 8240948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.